Global Women Health Therapeutics Market Research and Forecast 2017-2022

Orion Market Research Pvt. Ltd.

Industry Market Research Report and Consulting

Women Health Therapeutics Market, Size, Share, Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2017-2022

Rising awareness among women related to health issues in developing regions is propelling the women health therapeutic market”

— OMR Analyst

INDORE, INDIA, March 9, 2018 /EINPresswire.com/ — Orion Market Research (OMR), recently published a market research report on Global Women Health Therapeutics Market. According to OMR analysis, the global women health therapeutics market is expected to grow at a CAGR 4.4% during 2017-2022. Global women health therapeutics market is segmented on the basis of health disorder and regional outlook. Major players contributing to the growth of global women health therapeutics market include Abbott Laboratories, Pfizer, Inc., Eli Lilly and Company, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd. and Novo Nordisk A/S. The report includes detailed & insightful chapters on market overview, key findings, strategic recommendations, methodology, market determinants, key strategies, key company analysis, market insights, Patent analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

The full report of global women health therapeutics market is available https://www.omrglobal.com/industry-reports/women-health-therapeutics-market/

The rising incidences of chronic disorders in women is one of the most significant factors contributing to the growth of the women health therapeutics market. Breast cancer is one of the severe health issue faced by women globally. Breast cancer is the most commonly diagnosed cancer among American women. In 2017, it's estimated that around 30% of newly diagnosed cancers in women were breast cancers. According to breast cancer organization, estimate 266,000 new breast cancer cases are anticipated to diagnosed in women in the US in 2018. About 50,000 women in the US are expected to lose their lives in 2018 from breast cancer. Breast cancer is typically detected either during a screening examination, before symptoms have developed, or after a woman notices a lump. Treatment usually involves either breast biopsy or mastectomy. Mammography, breast cancer tumor marker tests, blood chemistry and blood cells count tests are some of the major tests used to diagnose the breast cancer. The rising number of breast cancer disease in women augmenting the growth of women health therapeutic across the globe.

Geographically, the market is segmented into North America, Europe, APAC and rest of the world. North America is expected to hold largest market share in the global market owing to the growing focus towards women health and high prevalence of chronic disorders such as breast cancer and lung cancer. In 2017, approximately 40,610 women died due to breast cancer in the US. The rapidly developing economies of APAC are projected to witness the highest growth rate due to the growing awareness about the diversified treatment options for women health issues coupled with the rising prevalence of urological disorders within the regional countries.

Company profiled in the report:

• Abbott Laboratories
• Amgen, Inc.
• Astellas Pharma Inc.
• Bayer AG
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Novartis International AG
• Novogyne Pharmaceuticals
• Novo Nordisk A/S
• Pfizer, Inc.
• Oasmia Pharmaceutical Company
• Radius Health Company
• Repros Therapeutics Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Tsumura & Co.
• Warner Chilcott Corp.
• Zosano Pharma Inc.

For related reports please visit:
https://www.omrglobal.com/reports-category/pharmaceuticals/
https://www.omrglobal.com/reports-category/medical-devices/

The report covers:
• Comprehensive research methodology of global women health therapeutics market.
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global women health therapeutics market.
• Insights about market determinants which are stimulating the women health therapeutics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company Profiling, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provides a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here


Source: EIN Presswire